Physician profile
Eric Reeves
NPI 1437698602
$10,425.80
in general payments reported to CMS, 2019-2025
47 companies · $3,023 in 2025
The $3,023 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $1,525 · 2023: $2,564 · 2024: $2,868 · 2025: $3,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,180 · Travel and Lodging: $249 · Education: $25.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,180.12 |
| Travel and Lodging | $249.06 |
| Education | $25.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,284.14 | 2021-2025 | |
| Emd Serono, INC. | $1,327.70 | 2022-2025 | Mavenclad, Mavenclad |
| Livanova USA, INC. | $960.82 | 2022-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $504.14 | 2022-2025 | Briviact, Nayzilam, Fintepla |
| Sk Life Science, INC. | $406.85 | 2022-2025 | |
| Pfizer INC. | $330.52 | 2023-2025 | |
| Lundbeck LLC | $268.84 | 2022-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $258.34 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Lilly USA, LLC | $225.22 | 2021-2025 | Kisunla, Emgality, Amyvid |
| Alexion Pharmaceuticals, INC. | $206.11 | 2022-2025 | Ultomiris |
| Argenx US, INC. | $205.55 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $202.12 | 2022-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $197.52 | 2023-2025 | |
| Genzyme Corporation | $193.16 | 2021-2025 | |
| Biogen, INC. | $156.01 | 2021-2025 | Leqembi, Vumerity, Tysabri |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.